Primary Cutaneous Gamma-Delta T-Cell Lymphoma

Explore clinical trials studying Primary Cutaneous Gamma-Delta T-Cell Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Primary Cutaneous Gamma-Delta T-Cell Lymphoma trial results

Recruiting

NCT05475925

Conditions: Aggressive NK Cell Leukemia, Cutaneous PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker), Cytotoxic PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker), +27 more
Locations: Dren Investigational Site Birmingham, Alabama, United States

Dren Investigational Site Duarte, California, United States

Dren Investigational Site Irvine, California, United States

Dren Investigational Site Redwood City, California, United States

View all 37 locations